Ashleigh Hull

Years Active: 2020-2023
Publications (10 Years): 5

University of South Australia

University of South Australia (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of South Australia Feb 11 2019

Australia

PhD Candidate :: School of Health Science

Education History

University of South Australia

Australia

BSC

Publications

Ashleigh Hull, William Hsieh, William Hsieh, Dylan Bartholomeusz, Yanrui Li, Eva Bezak
In vitro characterisation of [ 177 Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer. EJNMMI radiopharmacy and chemistry 8 (1) (2023)
Ashleigh Hull, William Hsieh, Artem Borysenko, William Tieu, Dylan Bartholomeusz, Eva Bezak
Development of [ 225 Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration. EJNMMI radiopharmacy and chemistry 8 (1) (2023)
Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz, William Hsieh, William Tieu, Tara Louise Pukala, Alexander H Staudacher, Eva Bezak
Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma. Cells 11 (19) (2022)
Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz, William Hsieh, Samantha Escarbe, Andrew Ruszkiewicz, Eva Bezak
The Expression Profile and Textural Characteristics of C595-Reactive MUC1 in Pancreatic Ductal Adenocarcinoma for Targeted Radionuclide Therapy. Cancers 13 (1) (2020)
Ashleigh Hull, Yanrui Li, Dylan Bartholomeusz, William Hsieh, Barry Allen, Eva Bezak
Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature. Cancers 12 (2) (2020)

Ashleigh Hull.css-eqlu8i{font-size:small;padding-left:4px;}